Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan.
Phase of Trial: Phase III
Latest Information Update: 06 Jun 2016
At a glance
- Drugs Minodronic acid (Primary) ; Alendronic acid
- Indications Bone resorption; Osteoporosis; Postmenopausal osteoporosis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Ono Pharmaceutical
- 05 Nov 2010 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History